21Doctors
Overview
21Doctors is a healthtech startup that specializes in Arabic-focused AI medical technologies. Established in 2022 by entrepreneurs Osama Almabroum and Rania Abu Taleb, the company was initially based in Jordan before relocating its headquarters to Saudi Arabia. The company's mission is to leverage AI to bridge the gap between global technological advances and the unique needs of Arabic-speaking patients, doctors, and healthcare institutions. As of recent updates in 2025, 21Doctors has raised an undisclosed amount in a pre-seed funding round supported by a group of regional angel investors.
Recent Developments
-
September 2025: 21Doctors closed a pre-seed funding round from angel investors, marking a significant step in its mission to build an Arabic-first AI medical infrastructure.
- The new funding will fuel expansion initiatives across the Gulf Cooperation Council (GCC) countries and North Africa.
- The company's focus is to support Saudi Arabia's Vision 2030 objectives by enhancing the country's healthcare digitization via AI-driven medical solutions tailored for Arabic speakers.
-
July 2025: The company launched new services aimed at improving AI-assisted diagnostic support and secure platforms for electronic medical records (EMR), which adhere to regional regulations.
- This initiative aims to digitize medical records and streamline healthcare provider interactions within the Arab world.
-
February 2025: 21Doctors formed strategic partnerships with several local healthcare providers in Saudi Arabia and Jordan to pilot their AI technologies, helping practitioners improve clinical decision-making processes.
-
October 2024: Co-founders Almabroum and Abu Taleb emphasized the importance of being headquartered in Saudi Arabia for rapid scalability and access to the rich talent pool in Jordan, boosting the company's cross-border operational capabilities.
- They announced intentions to onboard additional partners across the GCC, focusing on collaborative efforts in the region's burgeoning digital healthcare landscape.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2022 |
| Headquarters | Riyadh, Saudi Arabia |
| Founders | Osama Almabroum, Rania Abu Taleb |
| Key Investors | Angel investors (specific names undisclosed) |
| Industry | Healthtech |
| Core Mission | Building AI-powered Arabic-first medical infrastructure |
Early History
21Doctors was founded in 2022 by Osama Almabroum and Rania Abu Taleb in Jordan, with the vision to reimagine healthcare for the Arab world through advanced AI technologies. The idea stemmed from the noticeable gap in technological advancements and their implementation in Arabic-speaking countries. The founders recognized the need for solutions tailored to the cultural, linguistic, and regulatory needs of the region, which led to the birth of 21Doctors. Within its first year, the startup made significant strides by collaborating with local healthcare providers and initiating pilot programs focused on AI-driven diagnostics, eventually relocating its headquarters to Saudi Arabia to leverage its strategic position for regional business expansion.
Company Profile and Achievements
21Doctors has quickly established itself as a pioneer in the Arabic healthtech space, focusing on AI-driven medical solutions that integrate seamlessly with existing healthcare systems in the Middle East. Their business model revolves around creating tools and platforms that cater specifically to the linguistic and cultural context of Arabic-speaking countries.
- AI Infrastructure Development: Early on, the company invested in the development of a robust AI infrastructure capable of offering precise diagnostic insights and efficient data management solutions.
- Strategic Partnerships: By 2025, 21Doctors established strategic partnerships with healthcare providers across Saudi Arabia and Jordan, allowing them a real-world testing ground for their technologies.
- Vision 2030 Alignment: The company aligns its goals with Saudi Arabia's Vision 2030, aiming to transform the country into a digital hub for healthcare innovation.
Current Operations and Market Position
As of 2025, 21Doctors operates from its central base in Saudi Arabia, actively growing its market presence across the Gulf and North Africa. The startup is well-positioned within the competitive healthtech landscape due to its unique focus on Arabic-language AI medical solutions. Its competitive advantage lies in its ability to deliver culturally and linguistically appropriate technologies that drive efficiency in healthcare service delivery. The company continues to expand its technological capabilities, bolstered by new funding and strategic regional partnerships that enhance its ability to meet the specific demands of the Arabic-speaking healthcare market.
Conclusion
21Doctors is at the forefront of healthtech innovation in the Middle East, offering AI-driven solutions that address the nuanced needs of Arabic-speaking medical providers. By aligning strategic goals with regional economic plans like Saudi Arabia's Vision 2030, the company is poised for significant growth and impact. As it continues to expand its technological offerings and strengthen partnerships, 21Doctors has the potential to transform how healthcare is delivered in the Arab world, setting a new precedent for linguistic and cultural inclusivity in medical technology.